Paramedic Drug Test 4

Front 1

Albuterol class

Back 1

sympathpometic bronchodilator

Front 2

Albuterol mechanism of action

Back 2

sendative basta-2 agonist that stimulates adrenic receptors of the sympathomimetic nervous system resultin in smotth muscle relaxation in the bronchial tree and peripheral vasculature

Front 3

Albuterol Indication

Back 3

treatment of bronchospasm in patients with reversable obstructive airway disease (COPD/asthma) prevention of exercise induced bronchospasm

Front 4

Albuterol contraindications

Back 4

known priop hypersensitivity reactions to albuterol. tachycardia arrhythmias, especially those caused by digitalis. synergistic with other sympathomimetics

Front 5

Albuterol adverse reactions

Back 5

often dose-related and include restlessness, tremors, dizziness, palpitations, tachycardia, nervousness, peripheral vasodilation, nausea, vommiting, hyperglycemia, increased bp, paradoxial bronchospasm

Front 6

Albuterol Drug interactions

Back 6

tricylic antidepressants may potentiate vasculature effects. Beta blockers are antagonistic. May potentiate hypokalemia caused by diuretics

Front 7

Albuterol adult dose

Back 7

2.5mg dilute .5mL of .5% solution for inhalation with 2.5mL NS in nebulizer admin over 10 - 15 min. MDI: 1-2 inhalations of .01-.03mL (.05-.15mg/kg/dose) rpt 3x in 20min

Front 8

Albuterol duration of action

Back 8

onset 5-10 min fo rpeak 30min to 2 hours 3-4 hours

Front 9

dextrose 50%(D50) class

Back 9

carbohydrate, hypotonic solution

Front 10

dextrose 50%(D50) mechanism of action

Back 10

rapidly increases serum glucose levels. short-term osmotic diuretics

Front 11

dextrose 50%(D50) indications

Back 11

hyperglycemia, altered level of consciousness, coma of unknown etiology, seizure of unknown etiology, status epilepticus.

Front 12

dextrose 50%(D50) contraindications

Back 12

intracranial hemorrhage

Front 13

dextrose 50%(D50) adverse reactions

Back 13

extravastion leads to tissue necrosis. warmth, pain, burning, thrombophlebitis, rhabdomyolsis, hyperglycemia

Front 14

dextrose 50%(D50) drug interactrions

Back 14

sodium bicard, coumadin

Front 15

dextrose 50%(D50) dosage

Back 15

adult 12.5 - 25g slow IV

Front 16

dextrose 50%(D50) duration

Back 16

onset: hours peak: 8-12 duration: 24-72

Front 17

glucagon class

Back 17

hyperglycemic agent pancreatic hormone, insulin antagonist

Front 18

glucagon mechanism of action

Back 18

increase blood glucose level by stimulating glycogenesis. unknown menchanism of stablizing cardiac rhythm ion beta blocker overdose. Minimal positive inotropic and chronotropic response. decreases gastrointestinal motility and secretions

Front 19

glucagon indications

Back 19

altered level of consciousness when hypoglycemia is suspected. May be used as inotropic agent in beta blocker overdose.

Front 20

glucagon contraindications

Back 20

hyperglycemia, hypersensitivity

Front 21

glucagon adverse reactions

Back 21

nausea, vomiting, tachycardia, hypertension

Front 22

glucagon drug interactions

Back 22

incompatible in solution with most other substances. no signigicant drug interactions with other emergency medications.

Front 23

glucagon doseage

Back 23

adult: .5-1.0 mg IM repeat 7-10 min calcium channel blocker or beta blocker OD : 3mg initially followed 3mg/hr infusion

Front 24

glucagon duration of action

Back 24

onset: 1min peak 30min duration: variable (9-17 normal)

Front 25

Phenergan (promethazine) class

Back 25

antihistamine

Front 26

Phenergan (promethazine) mechanism of action

Back 26

h-1 receptor antagonist; blocks action of histamine; possesses sedative, anti-motion, antiemetic and anticholinergic activity, potentiates the effects of narcotics to induce analgesia

Front 27

Phenergan (promethazine) indications

Back 27

nausea, vomitting, motionsickness sedation for patients in labor, potentation of analegics effects of narcotics

Front 28

Phenergan (promethazine) contraindications

Back 28

hypersensitivity, coma, cns-depressed pts from alcohol, barbituates, narcotics, reye's syndrome

Front 29

Phenergan (promethazine) Adverse Reactions

Back 29

Sedations, dizziness, impairment of mental and physical ability, arrhythmias, nausea, vomiting, hyperexcitability, halucinations, convulsions, and suddend death when used in children

Front 30

Phenergan (promethazine) Drug interactions

Back 30

Additive with other CNS depressants. Increased extrapyramidal effects with MAOIs

Front 31

Phenergan (promethazine) Dose and admin

Back 31

12.5 - 25mg IV Deep IM, PO rectally

Front 32

Phenergan (promethazine) duration of ations

Back 32

onset IV: Immediate. Peak effect: 30-60min duration 4-6 hours

Front 33

Diazepam (valium) class

Back 33

Benzodiazepine, sedative-hypnotic, anticovulsant

Front 34

Diazepam (valium) Mechanism of action

Back 34

potentiates effects of inhibatory neurotransmitters. Raises seizure threshold. induces amnesia and sedation

Front 35

Diazepam (valium) indications

Back 35

acute anxiety states. acute alcohol witdrawal, muscle relaxant, seizure activity, agitiation, analgesia for medical proceedures,

Front 36

Diazepam (valium) contraindications

Back 36

hypersensitivity, glaucoma, coma, shock, substance abuse, head injury

Front 37

Diazepam (valium) adverse reactions

Back 37

respiratory depression, hypotension, drowsiness, ataxia, reflex tachycardia, nausea, confussion, trombosis and phebitis

Front 38

Diazepam (valium) drug interactions

Back 38

incompatible with most drugs and fluids

Front 39

Diazepam (valium) doseage and admin

Back 39

seizure: adult 5-10mg IV q 10-15 min prm. (5mg every 5min) Max 30mg

Front 40

Diazepam (valium) Duration of action

Back 40

onset: 1-5min peak: minutes duration: 20 - 50min